Trouver le bon soutien est critique pour quiconque traite les lésions induites par les médicaments. Cette page compile les services professionnels, les spécialistes médicaux, les communautés de soutien entre pairs, et les ressources éducatives pour vous aider à naviguer le sevrage, la récupération, et la guérison.
Services de sevrage et de déprescription
Pour en savoir plus sur le sevrage hyperbolique et quand le sevrage est et n'est pas approprié, consultez notre FAQ sur le sevrage et le retrait.
Finding physicians who understand protracted withdrawal and medication-induced injury can be challenging. When searching, look for practitioners who explicitly practice deprescribing and who understand hyperbolic tapering based on receptor occupancy principles. Many deprescribing practitioners still use linear dose reductions, which are inadequate at lower doses. Ask specifically whether they taper using progressively smaller absolute reductions, use liquid formulations or compounding pharmacies for low-dose precision, and understand the Horowitz & Taylor research on receptor occupancy-guided tapering.
TaperClinic
Website: taperclinic.com
Format : Clinique externe entièrement virtuelle (couverture à l'échelle nationale aux États-Unis)
The only fully virtual outpatient clinic dedicated exclusively to tapering psychiatric medications. TaperClinic uses hyperbolic tapering with 5-10% dose reductions from the current dose every 2-4 weeks, slowing the rate toward the end — consistent with receptor occupancy principles. They taper benzodiazepines, SSRIs, SNRIs, TCAs, mood stabilizers, and antipsychotics. Includes weekly clinician-led group check-ins and an in-house advisory team for sleep, nutrition, and psychological support.
Outro Health
Website: outro.com
Format : Clinique virtuelle (États-Unis sélectionnés, en expansion)
Co-founded by Dr. Mark Horowitz — the researcher whose work on receptor occupancy (Horowitz & Taylor, Lancet Psychiatry, 2019) established the scientific basis for hyperbolic tapering. Outro provides clinician-guided antidepressant tapering using the hyperbolic method, with custom compounded doses for the tiny reductions needed at lower doses. Monthly clinician visits with support between appointments. Currently focused on antidepressants (SSRIs, SNRIs), with plans to expand to benzodiazepines and gabapentinoids.
Ressources et communautés éducatives
Sources d'information fiables, communautés de soutien entre pairs, et organisations de défense pour la sécurité des médicaments, le sevrage, et le consentement éclairé.
Inner Compass Initiative / The Withdrawal Project
Website: thewithdrawn.org / innercompassinitiative.org
Ressources dirigées par les pairs sur le sevrage des médicaments psychiatriques, y compris les outils de documentation, les conseils de sevrage, les réseaux de soutien, et les matériaux éducatifs enracinés dans l'expérience vécue.
Mad in America
Website: madinamerica.com
Site de nouvelles et de recherche de premier plan couvrant la psychiatrie critique, la sécurité des médicaments, et les expériences des patients. Présente le journalisme d'enquête, l'analyse scientifique, les récits personnels, et un blog avec une couverture en profondeur des effets des médicaments psychiatriques et du sevrage.
RxISK
Website: rxisk.org
Ressource gratuite et indépendante de sécurité des médicaments permettant aux patients de signaler les événements indésirables et de rechercher les expériences d'effets indésirables. Fondée par Dr. David Healy (psychiatre et pharmacologue), elle comprend une vaste analyse de blog sur les problèmes de sécurité des médicaments, les effets indésirables des médicaments, les syndromes de sevrage, et les défaillances réglementaires.
BenzoBuddies
Website: benzobuddies.org
Le plus grand et le plus long forum de soutien entre pairs dédié au sevrage des benzodiazépines. Les membres partagent les expériences de sevrage, la gestion des symptômes de sevrage, les stratégies de récupération, et le soutien émotionnel. Comprend des archives d'information étendues et une communauté vibrante de milliers de personnes.
Surviving Antidepressants
Website: survivingantidepressants.org
Communauté de soutien entre pairs complète et site de ressources concentré sur le sevrage des antidépresseurs et le syndrome de sevrage prolongé. Comprend les protocoles de sevrage détaillés, les informations sur les symptômes de sevrage, et les forums communautaires.
Benzodiazepine Information Coalition
Website: benzoinfo.com
Informations complètes et factuelles sur la pharmacologie des benzodiazépines, la dépendance, le sevrage, et le sevrage. Matériaux éducatifs étendus sur la sécurité et la gestion des benzodiazépines.
PSSD Network
Website: pssdnetwork.org
Dédié à la recherche, au soutien, et à la sensibilisation de la dysfonction sexuelle post-ISRS (PSSD). Comprend les résultats de la recherche, les expériences des patients, et la défense pour une meilleure reconnaissance et un meilleur traitement.
Moral Medicine
Website: moralmedicine.org
Organisation de défense des patients sensibilisant aux graves et durables effets secondaires des médicaments couramment prescrits, y compris la finastéride, les ISRS, et l'Accutane. Finance la recherche, amplifie les témoignages des patients, et plaide pour les traitements des conditions comme le syndrome post-finastéride et la dysfonction sexuelle post-ISRS.
Taper Community
Website: taper.community
Plateforme de soutien entre pairs pour réduire de manière sûre les médicaments psychiatriques via les conseils communautaires et les ressources basées sur les preuves. Présente les forums spécifiques aux médicaments, les journaux de sevrage partageables, et un répertoire des cliniciens favorables au sevrage.
SSRI Stories
Website: ssristories.net
Une archive de plus de 5 000 cas documentés de violence, de suicide, et d'événements comportementaux indésirables graves associés aux médicaments psychiatriques—principalement les ISRS et IRSN. Chaque entrée est tirée des rapports de nouvelles, des cas judiciaires, des dossiers de la FDA, et des comptes publiés. Le seul volume des incidents documentés fait de ceci l'un des records les plus complets des dommages associés aux médicaments psychiatriques qui existent.
Antidepressant Info
Website: antidepressantinfo.org
Organisation communautaire offrant des réunions de soutien hebdomadaires pour les personnes affectées par le sevrage des antidépresseurs. Fournit un espace régulier et structuré pour se connecter avec d'autres naviguant les symptômes de sevrage, les défis du sevrage, et la récupération—particulièrement précieux pour ceux qui se sentent isolés ou non soutenus par leurs prestataires médicaux.
PFS Foundation
Website: pfsfoundation.org
Soutient les patients éprouvant des effets indésirables persistants de la finastéride (Propecia) et finance la recherche sur les mécanismes et traitements du syndrome post-finastéride. Comprend les expériences des patients, les mises à jour de la recherche, et la défense des droits.
Fluoroquinolone Toxicity Study
Website: fq100.org
Research and community resource for people experiencing adverse effects from fluoroquinolone antibiotics. Includes research findings, symptom documentation, and peer support for those dealing with FQAD.
Alliance for Benzodiazepine Best Practices
Website: benzoreform.org
Advocacy and education organization focused on promoting safer benzodiazepine prescribing and awareness of withdrawal risks. Includes clinical guidelines and patient education materials.
Psychiatric Medication Awareness Group
Website: psychmedaware.org
Educational organization providing resources about psychiatric medication adverse effects, withdrawal, and informed consent in psychiatric treatment.
Groupes Meta
Les communautés de soutien gérées par les pairs sur Meta offrent un soutien par les pairs accessible et en temps réel. Ce sont des groupes gérés par des profanes où les gens partagent leurs expériences et s'offrent mutuellement du soutien.
- Benzo Warrior Community (BWC) — Large community for benzodiazepine withdrawal and recovery
- Benzodiazepine Withdrawal Support Group — Peer support for those tapering benzodiazepines
- Healing from Psych Drugs — General psychiatric medication withdrawal and recovery
- Fluoroquinolone Toxicity Syndrome Network — Support for fluoroquinolone antibiotic adverse effects
- PSSD Worldwide Support — Dedicated to Post-SSRI Sexual Dysfunction support
- PFS Foundation Community — Community support for Post-Finasteride Syndrome sufferers
- Accutane Long-Term Side Effects — Support community for those dealing with post-Accutane adverse effects
Note: Meta groups are peer-run communities. Quality, moderation, and accuracy vary. Use them for emotional support and shared experiences, but verify medical information with reliable sources and healthcare providers.
Dietary Interventions for Neurological Injury
A growing number of patients report significant improvement in neurological symptoms with strict ketogenic or carnivore diet adherence. While clinical trials specific to medication-induced injury are limited, the neuroprotective mechanisms of ketosis — reduced neuroinflammation, stabilized neuronal excitability, enhanced mitochondrial function, and reduced glutamate excitotoxicity — are well established and directly relevant to the neurological damage caused by psychiatric medications.
Metabolic Mind
Website: metabolicmind.org
A nonprofit initiative advancing metabolic psychiatry — the use of ketogenic and metabolic therapies for mental health and neurological conditions. Metabolic Mind funds research, provides educational resources for patients and clinicians, and maintains a growing evidence base on ketogenic interventions for brain-based conditions. Their peers and families section is a particularly useful starting point for patients exploring dietary approaches to neurological recovery.
The Lion Diet
Website: liondiet.com
An elimination-based carnivore protocol — eating exclusively ruminant meat, salt, and water — designed to identify and remove dietary triggers of inflammation and immune reactivity. Some patients with medication-induced neurological injury report that this strict elimination approach is more effective than standard ketogenic diets, potentially because it removes all plant-based compounds that could trigger immune or inflammatory responses in a sensitized nervous system. The site provides practical guidance on implementation, troubleshooting, and food reintroduction.
Note: Dietary interventions require strict adherence to see results — partial compliance typically does not produce meaningful benefit. Most patients who report improvement needed several weeks of strict adherence before noticing changes. Diet is not a cure, but for those it helps, it can meaningfully reduce the severity of symptoms. See our FAQ for more information.
Essential Books
Published works providing evidence-based analysis of psychiatric medication safety and informed consent:
Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America
Author: Robert Whitaker
A groundbreaking investigation into how psychiatric medications work, their long-term effects, and the epidemiological data showing rising rates of psychiatric disability in medicated populations. Essential reading for understanding the broader context of medication-induced harm.
Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide and Crime
Author: Peter Breggin, M.D.
Dr. Breggin examines the capacity of psychiatric medications to cause violent and impulsive behavior, withdrawal syndromes, and other serious adverse effects. Includes case studies and analysis of medication-induced injuries.
Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare
Author: Peter Gøtzsche, M.D.
A critical examination of pharmaceutical industry practices, conflicts of interest in drug approval and marketing, and the gap between industry-sponsored research and independent evidence. Provides context for understanding why medication harms are underrecognized.
The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs
Authors: Mark Horowitz, M.D., Ph.D. & David Taylor, Ph.D.
The first major clinical guideline to incorporate hyperbolic tapering principles into deprescribing protocols. Based on receptor occupancy pharmacology, it provides evidence-based schedules for gradually reducing psychiatric medications — directly challenging the rapid tapers still standard in most clinical settings. Essential for patients and clinicians seeking safe discontinuation strategies.
Brain Energy: A Revolutionary Breakthrough in Understanding Mental Health — and Improving Treatment for Anxiety, Depression, OCD, PTSD, and More
Author: Christopher M. Palmer, M.D.
A Harvard psychiatrist presents the theory that mental disorders are metabolic disorders of the brain. Palmer synthesizes decades of research linking mitochondrial dysfunction to psychiatric conditions and makes the case for metabolic interventions — including the ketogenic diet — as treatments for mental illness. Directly relevant to understanding why dietary approaches may help with medication-induced neurological injury.
Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression
Author: David Healy, M.D.
Healy — a psychopharmacologist and one of the earliest researchers to document SSRI-induced suicidality — exposes how clinical trial data was manipulated to conceal serious adverse effects of antidepressants. A foundational text for understanding how the pharmaceutical industry shaped the narrative around SSRI safety.
Shipwreck of the Singular: Healthcare's Castaways
Author: David Healy, M.D.
Healy's most recent work examines how modern healthcare systems abandon patients who fall outside standard treatment narratives — particularly those harmed by medications. He documents how individuals with drug-induced injuries become "castaways" in a system that cannot acknowledge their condition, making this perhaps the most directly relevant book for anyone navigating medication-induced harm.
Antidepressed: A Breakthrough Examination of Epidemic Antidepressant Harm and Dependence
Author: Beverley Thomson
A comprehensive breakdown of the growing crisis of antidepressant harm and dependence — how we got here, what's happening to patients worldwide, and where we go from here. Covers the medicalization of mental health, the power of the informed patient, safe antidepressant management and withdrawal, and firsthand patient experiences.
May Cause Side Effects: A Memoir
Author: Brooke Siem
A memoir of antidepressant withdrawal from one of the first generation of minors prescribed antidepressants. After fifteen years and over 32,000 pills — initially prescribed in the wake of her father's sudden death — Siem chronicles the excruciating year of withdrawal and identity reconstruction that followed her decision to come off medication. Winner of the 2023 Best Indie Book Award for Memoir.
Unshrunk: A Story of Psychiatric Treatment Resistance
Author: Laura Delano
Equal parts memoir, history, and manifesto from the founder of Inner Compass Initiative. Delano chronicles her thirteen-year journey through psychiatric diagnoses, institutionalization, and a cascade of nineteen medications before tapering off and reclaiming her identity beyond diagnostic labels. A powerful exploration of what it means to resist a system that pathologizes normal human experience.
Reporting Adverse Drug Events
The adverse event reporting system is deeply flawed — FAERS captures an estimated 1-10% of adverse reactions that actually occur, and regulatory action is almost always too late. But it still matters. The fluoroquinolone black box warning and the EMA's recognition of PSSD both trace back to accumulated reports. The system is broken, but each report makes the evidence base harder to dismiss. Filing takes about 15 minutes and costs nothing.
United States (FDA)
FDA MedWatch Program
Online reporting, phone, or mail submissions.
- Website: fda.gov/medwatch
- Online Form: MedWatch Online
- Phone: 1-888-SAFEFDA (1-888-723-3332)
European Union (EMA)
EudraVigilance Platform
Reports processed through national competent authorities.
- Website: EMA Pharmacovigilance
- Patient Reporting: Contact your national medicines authority
United Kingdom (MHRA)
Yellow Card Scheme
Online, app, or paper reporting.
- Website: yellowcard.mhra.gov.uk
- Phone: 0800 731 6789
You Do Not Need Your Doctor's Permission
In most countries, patients can report adverse drug reactions directly to regulatory agencies. You do not need to go through your healthcare provider, and you do not need them to agree that the medication caused your symptoms. If your physician dismissed your experience, report it anyway. The report is yours to file.
These resources are provided for informational purposes. Inclusion on this page does not constitute endorsement of any organization or individual. The presence of a resource here means it may be helpful for people seeking support or information about medication-induced injury; it does not imply that all content is accurate or that we agree with every statement made by these organizations.
Always work with qualified medical professionals when making decisions about your medications. Peer support and educational resources are valuable complements to, but not substitutes for, professional medical care. If you are experiencing medication side effects or withdrawal symptoms, consult with your healthcare provider or seek a second opinion from another qualified physician.